» Articles » PMID: 39291275

Main Diagnostic Criteria Usually Does Not Work for Autoimmune Pancreatitis Wrongly Presuming Malignancy

Overview
Publisher Wiley
Specialty Gastroenterology
Date 2024 Sep 18
PMID 39291275
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autoimmune pancreatitis (AIP) usually responds dramatically to steroid therapy. Occasionally, however, misdiagnosed patients have undergone pancreaticoduodenectomy. This study is aimed at providing useful information to improve the accuracy of diagnosis before surgery and thus avoid unnecessary resections in patients with AIP.

Methods: From January 2015 to February 2020, a series of patients were enrolled, having undergone pancreaticoduodenectomy for presumed malignancy. AIP diagnoses were confirmed by postoperative pathology. The demographic and clinical data of the AIP patients were evaluated. The main diagnostic criteria (HISORt, Asian, and ICDC) for AIP were applied to assess whether and how unnecessary surgery could have been avoided.

Results: A total of 124 cases of pancreaticoduodenectomy were performed for presumed malignancy. Six patients were diagnosed with benign disease and five with AIP. The prevalences of benign disease and AIP were 4.8% and 4%, respectively. Four patients were female and 1 male, with a mean age of 60.0 years old. Jaundice, pain, and weight loss were observed in 100%, 20%, and 40% of AIP patients, respectively. The radiologic features of the AIP patients were a diffusely enlarged gland (40.0%), a focally enlarged gland (40.0%), pancreatic ductal dilatation (60.0%), upstream parenchymal atrophy (20.0%), bile duct thickening (66.0%), and bile duct stricture (40.0%). Based on the diagnostic criteria for AIP, surgery could have been avoided in two cases.

Conclusions: IgG4 measurement and integrated use of major diagnostic criteria should be emphasized in every patient eligible for pancreaticoduodenectomies.

References
1.
McPhee J, Hill J, Whalen G, Zayaruzny M, Litwin D, Sullivan M . Perioperative mortality for pancreatectomy: a national perspective. Ann Surg. 2007; 246(2):246-53. PMC: 1933570. DOI: 10.1097/01.sla.0000259993.17350.3a. View

2.
de Pretis N, Crino S, Frulloni L . The Role of EUS-Guided FNA and FNB in Autoimmune Pancreatitis. Diagnostics (Basel). 2021; 11(9). PMC: 8470670. DOI: 10.3390/diagnostics11091653. View

3.
OReilly D, Malde D, Duncan T, Rao M, Filobbos R . Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol. 2014; 5(2):71-81. PMC: 4025075. DOI: 10.4291/wjgp.v5.i2.71. View

4.
Sandrasegaran K, Menias C . Imaging in Autoimmune Pancreatitis and Immunoglobulin G4-Related Disease of the Abdomen. Gastroenterol Clin North Am. 2018; 47(3):603-619. DOI: 10.1016/j.gtc.2018.04.007. View

5.
de Castro S, de Nes L, Nio C, Velseboer D, Ten Kate F, Busch O . Incidence and characteristics of chronic and lymphoplasmacytic sclerosing pancreatitis in patients scheduled to undergo a pancreatoduodenectomy. HPB (Oxford). 2010; 12(1):15-21. PMC: 2814399. DOI: 10.1111/j.1477-2574.2009.00112.x. View